Katherine A. Davies

Parkville, VIC 3052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Unconventional binding of calmodulin to CHK2 kinase inhibits catalytic activity.

Unconventional binding of calmodulin to CHK2 kinase inhibits catalytic activity.

Journal: The Biochemical journal

Published: September 07, 2025

Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis.

Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis.

Journal: Current opinion in structural biology

Published: April 30, 2024

Initiating or switching to insulin degludec/insulin aspart in a real-world population of adults with type 2 diabetes in Australia: results from a prospective, non-interventional study.

Initiating or switching to insulin degludec/insulin aspart in a real-world population of adults with type 2 diabetes in Australia: results from a prospective, non-interventional study.

Journal: Internal medicine journal

Published: September 27, 2023

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization.

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization.

Journal: Nature communications

Published: June 23, 2023

From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors.

From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors.

Journal: Journal of medicinal chemistry

Published: February 13, 2023

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase.

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase.

Journal: The Biochemical journal

Published: February 09, 2023

Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.

Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.

Journal: Nature communications

Published: June 29, 2021

Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL.

Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL.

Journal: Cell death and differentiation

Published: April 29, 2021

MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis.

MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis.

Journal: Nature communications

Published: April 07, 2020

Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using Monobodies.

Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using Monobodies.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 03, 2020

Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologues.

Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologues.

Journal: Nature communications

Published: February 13, 2020

The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis.

The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis.

Journal: Cell death and differentiation

Published: November 12, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026